Physician profile
Ruby Havistin
NPI 1477999159
$3,980.92
in general payments reported to CMS, 2019-2025
11 companies · $35.19 in 2025
The $35.19 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $305 · 2021: $22.75 · 2023: $2,438 · 2024: $725 · 2025: $35.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,305 · Food and Beverage: $740 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,305.38 |
| Food and Beverage | $740.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $152.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,698.98 | 2023-2024 | Ffrct |
| Abbott Laboratories | $1,251.43 | 2019-2024 | Mitraclip |
| Biotronik INC. | $176.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $172.83 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $162.22 | 2019-2024 | Camzyos |
| Abiomed | $123.67 | 2020 | |
| Amgen INC. | $90.36 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $81.34 | 2024 | Arcalyst |
| Pfizer INC. | $77.10 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.28 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $71.45 | 2019-2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Havistin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.